Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Eight genomic clones of potato calmodulin (
PCM1
to 8) were isolated and characterized. Sequence comparisons of different genes revealed that the deduced amino acid sequence of
PCM1
had several unique substitutions, especially in the fourth Ca(2+)-binding area. The expression patterns of different genes were studied by northern analysis using the 3'-untranslated regions as probes. The expression of
PCM1
, 5, and 8 was highest in the stolon tip and it decreased during tuber development. The expression of PCM6 did not vary much in the tissues tested, except in the leaves, where the expression was lower; whereas, the expression of PCM4 was very low in all the tissues. The expression of PCM2 and PCM3 was not detected in any of the tissues tested. Among these genes, only
PCM1
showed increased expression following touch stimulation. To study the regulation of
PCM1
, transgenic potato plants carrying the
PCM1
promoter fused to the
beta-glucuronidase
(GUS) reporter gene were produced. GUS expression was found to be developmentally regulated and touch-responsive, indicating a positive correlation between the expression of
PCM1
and GUS mRNAs. These results suggest that the 5'-flanking region of
PCM1
controls developmental and touch-induced expression. X-Gluc staining patterns revealed that GUS localization is high in meristematic tissues such as the stem apex, stolon tip, and vascular regions.
...
PMID:Calmodulin gene family in potato: developmental and touch-induced expression of the mRNA encoding a novel isoform. 772 47